acetylcysteine has been researched along with Respiratory Distress Syndrome in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (6.15) | 18.7374 |
1990's | 21 (32.31) | 18.2507 |
2000's | 27 (41.54) | 29.6817 |
2010's | 7 (10.77) | 24.3611 |
2020's | 6 (9.23) | 2.80 |
Authors | Studies |
---|---|
Adir, Y; Alyan, M; Arber Raviv, S; Dor, E; Egorov, E; Farkash, S; Flikshtain, OD; Gal, Y; Harush, MY; Kaneti, G; Korach-Rechtman, H; Koren, L; Mekies, LN; Nudelman, I; Pieters, C; Saadya, A; Schroeder, A; Shainsky, J; Shklover, J; Zano, A | 1 |
Izquierdo-Alonso, JL; Peces-Barba, G; Pérez-Rial, S; Rivera, CG | 1 |
Baratashvili, N; Gvaramia, L; Kandelaki, M; Samsonia, M | 1 |
Calkovska, A; Hanusrichterova, J; Kolomaznik, M; Kosutova, P; Mikolka, P; Mokra, D; Vatecha, M; Zila, I | 1 |
Bhatnagar, M; Jaiswal, N; Shah, H | 1 |
Zhang, S; Zhang, X; Zhao, Y | 1 |
Lambert, AA; Moon, KK; Parker, AM | 1 |
Kang, S | 1 |
Chao, J; Chao, L; Chen, CW; Huang, YW; Lin, CF; Lin, WC; Lin, YS | 1 |
Ditch, KL; Dube, KM; Hills, L | 1 |
Bhullar, IS; Royall, N; Smith, H; Warren, B | 1 |
Ghahremani, MH; Hajibabayee, M; Khajavi, MR; Mandegari, A; Mojtahedzadeh, M; Moradi, M; Najafi, A; Soltan-Sharifi, MS | 1 |
Cansu, A; Erol, MM; Erturk, E; Tatli, O; Turedi, S; Yeniocak, S | 1 |
Chen, J; Guan, XD; Li, XF; Ouyang, B; Wu, JF | 1 |
Baboolal, HA; Bloch, KD; Ichinose, F; Kawai, N; Ullrich, R; Zapol, WM | 1 |
Hales, CA; Jafari, B; Li, LF; Ouyang, B; Quinn, DA | 1 |
Bouchier-Hayes, D; Condron, C; Kearns, S; Murray, P; Power, C; Street, J; Thornes, B; Timlin, M; Toomey, D | 1 |
Adhikari, N; Burns, KE; Meade, MO | 2 |
Atik, U; Cinel, I; Cinel, L; Ercan, B; Ercil, M; Kanik, A; Koksel, O; Ozdulger, A; Tamer, L | 1 |
Eriksson, C; Jansson, AH; Wang, X | 1 |
Balkan, A; Balkan, M; Bilgic, H; Erdem, O; Kiliç, S; Korkmaz, A; Kutsal, O; Yasar, M | 1 |
Andrades, M; da Cunha, AA; Dal-Pizzol, F; Echer, IC; Lucchiari, N; Menna-Barreto, S; Moreira, JC; Reinke, A; Ritter, C; Rocha, J; Streck, EL | 1 |
Cross, CE; Halliwell, B; van Asbeck, BS | 1 |
Bozkurt, AK; Cortelekoglu, T; Koksal, C; Konukoglu, D; Musellim, B; Sayin, AG; Sirin, G; Ustundag, N | 1 |
Alkan, A; Alsancak, G; Cerçi, C; Ergin, C; Eroğlu, E; Eroğlu, F | 1 |
Benjamin, SP; Fernando, ME; Jayanth, JJ; Preetha, B | 1 |
Barnes, K; Biswal, S; Crow, MT; Dodd-O, JM; Grigoryev, DN; Hassoun, PM; Kensler, TW; Mitzner, W; Papaiahgari, S; Reddy, NM; Reddy, SP; Reddy, SR; Tuder, RM; Yamamoto, M; Yerrapureddy, A | 1 |
Abdollahi, M; Mohammadirad, A; Mojtahedzadeh, M; Moradi, M; Najafi, A; Reza Khajavi, M; Reza Rouini, M; Soltan-Sharifi, MS | 1 |
Beltz, EA; Bream-Rouwenhorst, HR; Moores, KG; Ross, MB | 1 |
Chen, HI; Kao, SJ; Liu, DD | 1 |
Molnár, Z | 1 |
Flierl, MA; Hoesel, LM; McClintock, SD; Niederbichler, AD; Pianko, MJ; Reuben, JS; Rittirsch, D; Sarma, JV; Smith, M; Stone, W; Ward, PA; Yang, H | 1 |
Hales, CA; Jafari, B; Quinn, DA; Syrkina, O | 1 |
Bernard, GR; Christman, BW | 1 |
De Wit, N; Gillet, R; Huyghens, L; Spapen, H; Zhang, H | 1 |
Beehler, CJ; Hybertson, BM; Leff, JA; Repine, JE; Shanley, PF; Wilke, CP | 1 |
Domenighetti, G; Laverrière, MC; Perret, C; Ritz, R; Schaller, MD; Suter, PM | 1 |
Barth, P; Feddersen, CO; Püchner, A; von Wichert, P | 1 |
Feihl, F; Laurent, T; Markert, M; Perret, C; Schaller, MD | 1 |
Blackwell, TR; Blackwell, TS; Christman, BW; Christman, JW; Holden, EP | 1 |
Benson, PF; Doctrow, SR; Fink, MP; Gonzalez, PK; Malfroy, B; Menconi, MJ; Zhuang, J | 1 |
Amsel, B; Bossaert, L; De Backer, WA; Hiemstra, PS; Jorens, PG; van Noort, P; van Overveld, FJ | 1 |
Kasper, M; Morin, AM; Suhayda, A; von Schmädel, E; Zähringer, J | 1 |
Arons, MM; Bernard, GR; Morris, PE; Paz, HL; Russell, JA; Wheeler, AP; Wright, PE | 1 |
Domenighetti, G; Perret, C; Ritz, R; Schaller, MD; Suter, PM | 1 |
Fukumoto, T; Moriuchi, H; Yuizono, T; Zaha, M | 1 |
Ruffmann, R | 1 |
Lee, A; Walsh, TS | 1 |
Conti, A; De Gaudio, AR; Masoni, M; Novelli, G; Ortolani, O | 1 |
Fan, J; Kapus, A; Li, YH; Marshall, JC; Rizoli, S; Rotstein, OD | 1 |
Bossaert, L; De Backer, W; Jorens, PG; Lenz, AG; Maier, KL; Meyer, B; Van Overveld, F | 1 |
Fan, J; Li, YH; Oreopoulos, GD; Rotstein, OD; Shek, PN; Suntres, ZE | 1 |
Gon, Y; Hashimoto, S; Horie, T; Koura, T; Matsumoto, K; Nakayama, T; Takeshita, I | 1 |
Eaton, S; Martin, G | 1 |
Bulger, EM; Garcia, I; Maier, RV | 1 |
Bud, MI; Herlevsen, P; Jepsen, S; Klausen, NO; Knudsen, P | 1 |
Ruffmann, R; Wendel, A | 1 |
Bernard, GR | 2 |
Brigham, KL | 1 |
Bebout, DE; Glennow, C; Gray, AT; Mathieu-Costello, O; Natterson, PD; Wagner, PD | 1 |
Braganza, JM; Holmes, AM; Kisher, R; Ku, R; Morton, AR; Stalley, L | 1 |
Andersen, JB; Bud, MI; Hjortsø, E; Jensen, NK; Jones, R; Qvist, J; Reid, LM; Thomsen, JL; Wiberg-Jørgensen, F; Zapol, WM | 1 |
Saldeen, T; Sandhagen, B; Wegener, T | 1 |
14 review(s) available for acetylcysteine and Respiratory Distress Syndrome
Article | Year |
---|---|
N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions.
Topics: Acetylcysteine; COVID-19 Drug Treatment; Humans; Immunotherapy; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
[Progress of the antioxidant effect of N-acetylcysteine in treatment of acute respiratory distress syndrome].
Topics: Acetylcysteine; Animals; Antioxidants; China; Oxidative Stress; Respiratory Distress Syndrome | 2020 |
Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Alprostadil; Humans; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome | 2004 |
Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Alprostadil; Humans; Pentoxifylline; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Distress Syndrome; Surface-Active Agents; Vasodilator Agents | 2004 |
Recent developments in the management of acute respiratory distress syndrome in adults.
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Albuterol; Bronchodilator Agents; Expectorants; Fluid Therapy; Humans; Nitric Oxide; Prone Position; Prostaglandins; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome; Tidal Volume | 2008 |
Antilipid mediator and antioxidant therapy in adult respiratory distress syndrome.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Antioxidants; Clinical Trials as Topic; Disease Models, Animal; Epoprostenol; Humans; Inflammation; Intensive Care Units; Leukotrienes; Lipid Peroxidation; Middle Aged; Platelet Activating Factor; Respiratory Distress Syndrome; Thromboxanes; Treatment Failure | 1993 |
[Acetylcysteine: a promising antioxidant for cardiorespiratory disorders].
Topics: Acetaminophen; Acetylcysteine; Acquired Immunodeficiency Syndrome; Antioxidants; Chemical and Drug Induced Liver Injury; Humans; Myocardial Reperfusion Injury; Nitrates; Reactive Oxygen Species; Respiratory Distress Syndrome | 1994 |
Role of oxidant stress in the adult respiratory distress syndrome: evaluation of a novel antioxidant strategy in a porcine model of endotoxin-induced acute lung injury.
Topics: Acetylcysteine; Adult; Animals; Catalase; Disease Models, Animal; Endotoxins; Ethylenediamines; Free Radical Scavengers; Humans; Lipopolysaccharides; Lung; Lung Injury; Organometallic Compounds; Oxidative Stress; Reactive Oxygen Species; Respiratory Distress Syndrome; Superoxide Dismutase; Swine; Thiourea | 1996 |
N-acetylcysteine administration in the critically ill.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiovascular System; Critical Illness; Free Radical Scavengers; Humans; Immune System; Liver Failure; Respiratory Distress Syndrome | 1999 |
Clinical developments for treating ARDS.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Animals; Anticoagulants; Antioxidants; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Expectorants; Hemodynamics; Humans; Hydrostatic Pressure; Immunotherapy; Nutritional Physiological Phenomena; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Therapy | 2002 |
GSH rescue by N-acetylcysteine.
Topics: Acetylcysteine; Acquired Immunodeficiency Syndrome; Glutathione; Humans; Pulmonary Fibrosis; Respiratory Distress Syndrome | 1991 |
N-acetylcysteine in experimental and clinical acute lung injury.
Topics: Acetylcysteine; Animals; Clinical Trials as Topic; Endotoxins; Free Radical Scavengers; Glutathione; Granulocytes; Humans; Lung Diseases; Models, Biological; Respiratory Distress Syndrome | 1991 |
Oxidant stress and adult respiratory distress syndrome.
Topics: Acetylcysteine; Animals; Free Radicals; Humans; Lung; Oxygen; Respiratory Distress Syndrome | 1990 |
ARDS after accidental inhalation of zinc chloride smoke.
Topics: Acetylcysteine; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chlorides; Humans; Lung; Military Personnel; Respiratory Distress Syndrome; Zinc; Zinc Compounds | 1988 |
11 trial(s) available for acetylcysteine and Respiratory Distress Syndrome
Article | Year |
---|---|
The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine.
Topics: Acetylcysteine; Acute Lung Injury; Adult; Antioxidants; Case-Control Studies; Chi-Square Distribution; Drug Administration Schedule; Female; Gene Frequency; Genotype; Glutathione Transferase; Humans; Male; Middle Aged; Oxidative Stress; Polymorphism, Genetic; Respiratory Distress Syndrome; Single-Blind Method; Treatment Outcome | 2009 |
Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms.
Topics: Acetylcysteine; Adult; Antioxidants; APACHE; Biomarkers; Blood Platelets; Female; Glutathione; Humans; Infusions, Intravenous; Male; Middle Aged; Oxidative Stress; Respiratory Distress Syndrome; Sulfhydryl Compounds; Treatment Outcome; Up-Regulation | 2007 |
N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Lung; Lung Injury; Male; Middle Aged; Oxygen Consumption; Oxygen Inhalation Therapy; Placebos; Respiration, Artificial; Respiratory Distress Syndrome; Risk Factors; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome | 1994 |
Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine.
Topics: Acetylcysteine; Acridines; Antioxidants; Double-Blind Method; Female; Glutathione; Granulocytes; Humans; Indicators and Reagents; Infusions, Intravenous; Leukocyte Elastase; Luminescent Measurements; Luminol; Male; Middle Aged; Oxidants; Pancreatic Elastase; Placebos; Reactive Oxygen Species; Respiratory Distress Syndrome | 1996 |
N-acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid.
Topics: Acetylcysteine; Aged; Bronchoalveolar Lavage Fluid; Cardiac Surgical Procedures; Double-Blind Method; Female; Free Radical Scavengers; Humans; Leukocyte Elastase; Male; Middle Aged; Neutrophils; Premedication; Respiratory Distress Syndrome | 1996 |
A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group.
Topics: Acetylcysteine; Adult; Antioxidants; Bilirubin; Bronchoalveolar Lavage Fluid; Cardiac Output; Cysteine; Double-Blind Method; Free Radical Scavengers; Glutathione; Humans; Middle Aged; Prospective Studies; Pyrrolidonecarboxylic Acid; Respiration, Artificial; Respiratory Distress Syndrome; Thiazoles; Thiazolidines; Time Factors | 1997 |
Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.
Topics: Acetylcysteine; Adult; Aged; Blood Coagulation; Double-Blind Method; Expectorants; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Oxygen; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome | 1997 |
Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome.
Topics: Acetylcysteine; Adult; Aged; APACHE; Breath Tests; Bronchoalveolar Lavage Fluid; Ethane; Female; Free Radical Scavengers; Glutathione; Glutathione Disulfide; Humans; Infusions, Intravenous; Lipid Peroxidation; Lung; Male; Malondialdehyde; Middle Aged; Respiratory Distress Syndrome; Respiratory Mucosa; Rutin; Time Factors | 2000 |
Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study.
Topics: Acetylcysteine; Adult; Aged; Antithrombin III; Double-Blind Method; Female; Fibrinogen; Humans; Lung Compliance; Male; Middle Aged; Oxygen; Partial Pressure; Platelet Count; Prospective Studies; Respiratory Distress Syndrome | 1992 |
N-acetylcysteine in experimental and clinical acute lung injury.
Topics: Acetylcysteine; Animals; Clinical Trials as Topic; Endotoxins; Free Radical Scavengers; Glutathione; Granulocytes; Humans; Lung Diseases; Models, Biological; Respiratory Distress Syndrome | 1991 |
Potential of N-acetylcysteine as treatment for the adult respiratory distress syndrome.
Topics: Acetylcysteine; Animals; Double-Blind Method; Free Radicals; Glutathione; Humans; Lymphocyte Activation; Methylprednisolone; Respiratory Distress Syndrome; Sheep | 1990 |
41 other study(ies) available for acetylcysteine and Respiratory Distress Syndrome
Article | Year |
---|---|
Lung targeted liposomes for treating ARDS.
Topics: Acetylcysteine; Animals; COVID-19; Humans; Inflammation; Lipopolysaccharides; Liposomes; Lung; Lung Diseases; Mice; Mice, Inbred C57BL; Nanoparticles; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha | 2022 |
NEUROPROTECTIVE AND ANTIOXIDANT POTENTIAL OF MONTELUKAST-ACETYLCYSTEINE COMBINATION THERAPY FOR BRAIN PROTECTION IN PATIENTS WITH COVID-19 INDUCED PNEUMONIA.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; COVID-19; Diabetes Mellitus, Type 2; Humans; Interleukin-6; Microcirculation; Middle Aged; Oxygen; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2 | 2023 |
Efficiency of exogenous surfactant combined with intravenous N-acetylcysteine in two-hit rodent model of ARDS.
Topics: Acetylcysteine; Animals; Antioxidants; Hyperoxia; Lung; Lung Injury; Pulmonary Surfactants; Rats; Rats, Wistar; Respiratory Distress Syndrome; Rodentia; Surface-Active Agents | 2023 |
N-acetycysteine: A potential therapeutic agent in COVID-19 infection.
Topics: Acetylcysteine; Antioxidants; COVID-19 Drug Treatment; Glutathione; Humans; Oxidation-Reduction; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Respiratory Distress Syndrome | 2020 |
High-dose N-acetylcysteine in chronic obstructive pulmonary disease, prone positioning in acute respiratory distress syndrome, and continuous positive airway pressure and exhaled nitric oxide in obstructive sleep apnea.
Topics: Acetylcysteine; Continuous Positive Airway Pressure; Free Radical Scavengers; Humans; Nitric Oxide; Prone Position; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Sleep Apnea, Obstructive | 2014 |
2014 American Thoracic Society International Conference.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Asthma; Congresses as Topic; Eosinophilia; Expectorants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Idiopathic Pulmonary Fibrosis; Indoles; Lung Neoplasms; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridones; Respiratory Distress Syndrome | 2014 |
Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Down-Regulation; Epithelial Cells; Fas Ligand Protein; fas Receptor; Humans; Inflammation; Lipopolysaccharides; Lung; Mice; NF-kappa B; Reactive Oxygen Species; Respiratory Distress Syndrome; Sepsis; Serpins; Signal Transduction | 2015 |
Use of Nebulized Heparin, Nebulized N-Acetylcysteine, and Nebulized Epoprostenol in a Patient With Smoke Inhalational Injury and Acute Respiratory Distress Syndrome.
Topics: Acetylcysteine; Administration, Inhalation; Anticoagulants; Antihypertensive Agents; Drug Therapy, Combination; Epoprostenol; Expectorants; Heparin; Humans; Male; Nebulizers and Vaporizers; Respiratory Distress Syndrome; Smoke Inhalation Injury; Young Adult | 2017 |
Novel Treatment of Acute Respiratory Distress Syndrome after Chlorine Gas Inhalation Injury.
Topics: Acetylcysteine; Albuterol; Anticoagulants; Bronchodilator Agents; Chemical Warfare Agents; Chlorine; Expectorants; Heparin; Humans; Male; Middle Aged; Respiratory Distress Syndrome; Respiratory Therapy | 2016 |
Acute severe respiratory distress secondary to misuse of an N-acetylcysteine effervescent tablet.
Topics: Acetylcysteine; Administration, Oral; Aged; Antiviral Agents; Causality; Edema; Emergency Treatment; Glottis; Humans; Male; Medication Errors; Respiratory Aspiration; Respiratory Distress Syndrome; Solubility; Tablets | 2010 |
[N-acetylcysteine (NAC) inhibited pulmonary fibrosis in acute respiratory distress syndrome (ARDS)].
Topics: Acetylcysteine; Cells, Cultured; Collagen; Fibroblasts; Glutathione; Humans; Lipopolysaccharides; Lung; Pulmonary Fibrosis; Respiratory Distress Syndrome | 2011 |
Reactive oxygen species scavengers attenuate endotoxin-induced impairment of hypoxic pulmonary vasoconstriction in mice.
Topics: Acetylcysteine; Animals; Antioxidants; Cell Hypoxia; Endotoxins; Ethylenediamines; Female; Male; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organometallic Compounds; Peroxidase; Pulmonary Circulation; Reactive Oxygen Species; Respiratory Distress Syndrome; RNA, Messenger; Vasoconstriction | 2002 |
Intracellular glutathione in stretch-induced cytokine release from alveolar type-2 like cells.
Topics: Acetylcysteine; Antioxidants; Blotting, Northern; Buthionine Sulfoximine; Cells, Cultured; Cytokines; Epithelial Cells; Glutathione; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Isoprostanes; Lipid Peroxidation; NF-kappa B; Oxidative Stress; Pulmonary Alveoli; Respiratory Distress Syndrome; Stress, Mechanical; Transcription Factor AP-1 | 2004 |
N-acetylcysteine attenuates lung injury in a rodent model of fracture.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Femoral Fractures; Fracture Fixation, Intramedullary; Free Radical Scavengers; Lung; Male; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome | 2004 |
Effects of N-acetylcysteine on oxidant-antioxidant balance in oleic acid-induced lung injury.
Topics: Acetylcysteine; Animals; Antioxidants; Disease Models, Animal; Drug Administration Schedule; Female; Injections, Intravenous; Lung; Malondialdehyde; Oleic Acid; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Respiratory Distress Syndrome; Sodium-Potassium-Exchanging ATPase; Time Factors | 2004 |
Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Budesonide; Chemokine CCL2; Chemokine CXCL1; Chemokine CXCL2; Chemokines, CXC; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Instillation, Drug; Interleukin-1; Interleukin-6; Lipopolysaccharides; Lung; Organ Size; Pneumonia; Rats; Rats, Wistar; Respiratory Distress Syndrome; Total Lung Capacity; Tumor Necrosis Factor-alpha | 2005 |
Pulmonary protective effects of hyberbaric oxygen and N-acetylcysteine treatment in necrotizing pancreatitis.
Topics: Acetylcysteine; Animals; Ceruletide; Glutathione Peroxidase; Hyperbaric Oxygenation; Lung; Male; Malondialdehyde; Oxidative Stress; Pancreatitis, Acute Necrotizing; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Superoxide Dismutase | 2006 |
Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Deferoxamine; Disease Models, Animal; Interleukin-1; Lipopolysaccharides; Male; Oxidative Stress; Rats; Rats, Wistar; Respiratory Distress Syndrome; Siderophores; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2006 |
More antioxidants in sepsis: still paved with uncertainties.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Deferoxamine; Disease Models, Animal; Humans; Oxidation-Reduction; Oxidative Stress; Respiratory Distress Syndrome; Sepsis; Siderophores | 2006 |
Attenuation of acute lung injury following lower limb ischemia/reperfusion: the pharmacological approach.
Topics: Acetylcysteine; Animals; Aprotinin; Biomarkers; Calcium Dobesilate; Creatine Kinase; Disease Models, Animal; Drug Therapy, Combination; Free Radical Scavengers; Hemostatics; L-Lactate Dehydrogenase; Lower Extremity; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Respiratory Distress Syndrome; Thiobarbituric Acid Reactive Substances; Treatment Outcome | 2006 |
Protective effects of N-acetylcysteine and erdosteine on hemorrhagic shock-induced acute lung injury.
Topics: Acetylcysteine; Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Free Radical Scavengers; Glutathione; Lung; Macrophages, Alveolar; Male; Malondialdehyde; Neutrophils; Premedication; Random Allocation; Rats; Rats, Wistar; Respiratory Distress Syndrome; Shock, Hemorrhagic; Thioglycolates; Thiophenes | 2006 |
Cleistanthus collinus poisoning.
Topics: Acetylcysteine; Acidosis, Renal Tubular; Adult; Glycosides; Humans; Hypokalemia; Lignans; Male; Plant Leaves; Plant Poisoning; Plants, Toxic; Respiratory Distress Syndrome; Shock; Toxins, Biological; Treatment Outcome; Vasodilation | 2006 |
Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice.
Topics: Acetylcysteine; Animals; Antioxidants; Capillary Permeability; Cytokines; Disease Models, Animal; Free Radical Scavengers; Inflammation; Male; Mice; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; Respiratory Distress Syndrome; Ventilators, Mechanical | 2007 |
N-acetylcysteine attenuates acute lung injury induced by fat embolism.
Topics: Acetylcysteine; Animals; Embolism, Fat; Expectorants; Leukocyte Elastase; Male; Nitric Oxide Synthase Type II; Peroxidase; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome | 2008 |
N-acetylcysteine as the magic bullet: too good to be true.
Topics: Acetylcysteine; Animals; Disease Models, Animal; Embolism, Fat; Expectorants; Humans; Pulmonary Embolism; Respiratory Distress Syndrome | 2008 |
Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury.
Topics: Acetylcysteine; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Chemokines; Cytokines; Free Radical Scavengers; Humans; Liposomes; Lung; Macrophages, Alveolar; Male; Mustard Gas; Rats; Rats, Long-Evans; Respiratory Distress Syndrome; Tocopherols | 2008 |
Oxidant stress mediates inflammation and apoptosis in ventilator-induced lung injury.
Topics: Acetylcysteine; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Disease Models, Animal; Epithelial Cells; Free Radical Scavengers; Glutathione; Interleukin-6; Lung; Oxidative Stress; Pneumonia; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Ventilators, Mechanical | 2008 |
Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats.
Topics: Acetylcysteine; Animals; Disease Models, Animal; Glutathione; Glutathione Disulfide; Humans; Hydrogen Peroxide; Interleukin-1; Lung; Male; Neutrophils; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Respiration; Respiratory Distress Syndrome | 1993 |
[N-acetylcysteine decreases functional and structural, ARDS-typical lung changes in endotoxin-treated rats].
Topics: Acetylcysteine; Animals; Endotoxins; Lung; Perfusion; Rats; Reactive Oxygen Species; Respiratory Distress Syndrome; Salmonella enteritidis; Ventilation-Perfusion Ratio | 1993 |
In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Base Sequence; Chemokines, CXC; Chemotactic Factors; Chemotaxis, Leukocyte; Dinoprost; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxins; F2-Isoprostanes; Gene Expression Regulation; Glutathione; Growth Substances; Inflammation; Intercellular Signaling Peptides and Proteins; Leukocyte Count; Lung; Lung Diseases; Male; Molecular Sequence Data; Neutrophils; NF-kappa B; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; RNA, Messenger; Sepsis | 1996 |
[Acute respiratory insufficiency after inhaling concrete dust--a case report].
Topics: Acetylcysteine; Bronchoalveolar Lavage; Bronchoscopy; Construction Materials; Dust; Humans; Male; Middle Aged; Oxygen Inhalation Therapy; Radiography; Respiratory Distress Syndrome | 1997 |
Activation of polymorphonuclear leukocytes in oleic acid-induced lung injury.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Animals; Capillary Permeability; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Free Radical Scavengers; Guinea Pigs; Leukocyte Elastase; Male; Neutrophils; Oleic Acid; Prospective Studies; Pulmonary Circulation; Rats; Respiratory Distress Syndrome; Serine Proteinase Inhibitors; Superoxides | 1998 |
Reactive oxygen species in acute lung injury.
Topics: Acetylcysteine; Antioxidants; Humans; Reactive Oxygen Species; Respiratory Distress Syndrome | 1998 |
Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor.
Topics: Acetylcysteine; Animals; Antioxidants; Blood Coagulation Disorders; Bronchoalveolar Lavage Fluid; Capillary Leak Syndrome; Disseminated Intravascular Coagulation; Fibrin; Fibrinolysis; Gene Expression Regulation; Lipopolysaccharides; Lipoproteins; Macrophage Activation; Macrophages, Alveolar; Male; Models, Biological; Neutrophils; NF-kappa B; Oxidative Stress; Plasminogen Activator Inhibitor 1; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Respiratory Distress Syndrome; Shock, Hemorrhagic; Shock, Septic; Thromboplastin; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2000 |
Oxidatively modified proteins in bronchoalveolar lavage fluid of patients with ARDS and patients at-risk for ARDS.
Topics: Acetylcysteine; Adult; Aged; Bronchoalveolar Lavage Fluid; Female; Humans; Male; Methylprednisolone; Middle Aged; Oxidation-Reduction; Proteins; Reactive Oxygen Species; Respiratory Distress Syndrome; Risk Factors | 1999 |
Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome.
Topics: Acetylcysteine; Animals; Antioxidants; Chemokines, CXC; Chemotactic Factors; Drug Carriers; Gene Expression Regulation; Growth Substances; Hemorrhage; Injections, Intravenous; Intercellular Signaling Peptides and Proteins; Lipopolysaccharides; Liposomes; Lung; Male; Neutrophils; Peroxidase; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Resuscitation | 2000 |
N-acetyl-L-cysteine inhibits bleomycin-induced interleukin-8 secretion by bronchial epithelial cells.
Topics: Acetylcysteine; Antimetabolites, Antineoplastic; Antioxidants; Bleomycin; Bronchi; Cell Line; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Free Radical Scavengers; Humans; Interleukin-8; Pyrrolidines; Respiratory Distress Syndrome; Respiratory Mucosa; Thiocarbamates | 2000 |
Intracellular antioxidant activity is necessary to modulate the macrophage response to endotoxin.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Blood Coagulation Factors; Butylated Hydroxyanisole; Cells, Cultured; Chromans; Endotoxins; F2-Isoprostanes; Inflammation; Macrophages, Alveolar; Male; Rabbits; Reactive Oxygen Species; Respiratory Distress Syndrome; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2002 |
Protection against pulmonary O2 toxicity by N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Dogs; Free Radicals; Glutathione; Lung Diseases; Oxygen; Respiratory Distress Syndrome; Respiratory Function Tests | 1989 |
Acetylcysteine to treat complications of pancreatitis.
Topics: Acetylcysteine; Acute Disease; Humans; Male; Middle Aged; Pancreatitis; Respiratory Distress Syndrome | 1986 |
Effect of N-acetylcysteine on pulmonary damage due to microembolism in the rat.
Topics: Acetylcysteine; Animals; Blood Viscosity; Male; Pulmonary Embolism; Rats; Rats, Inbred Strains; Respiratory Distress Syndrome | 1987 |